 Rapid Influenza Diagnostic Testing Ridt Market Insights, Competitive Landscape, and Market Forecast - 2033
The Rapid Influenza Diagnostic Testing (RIDT) market is witnessing consistent expansion as healthcare systems prioritize early detection and rapid response to influenza infections. RIDTs are point-... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe Rapid Influenza Diagnostic Testing (RIDT) market is witnessing consistent expansion as healthcare systems prioritize early detection and rapid response to influenza infections. RIDTs are point-of-care diagnostic tools designed to deliver quick results, enabling healthcare professionals to initiate timely treatment and reduce the spread of infection. The growing emphasis on efficient disease management, combined with increasing awareness of respiratory illnesses, is fueling demand for these diagnostic solutions. The market is projected to reach USD 1.5 billion in 2026 and is anticipated to grow to USD 2 billion by 2033, registering a compound annual growth rate (CAGR) of 4.90% during the forecast period.Market Insights Rapid influenza diagnostic tests have become a vital component of clinical diagnostics due to their speed, ease of use, and accessibility. These tests are widely adopted across hospitals, clinics, and diagnostic laboratories for detecting influenza A and B viruses. The shift toward decentralized healthcare and point-of-care testing is significantly contributing to market growth. Continuous improvements in diagnostic technologies have enhanced the sensitivity and specificity of RIDTs, making them more reliable for clinical decision-making. Additionally, the integration of digital technologies is improving test result accuracy, patient data tracking, and overall healthcare efficiency, further strengthening market adoption. Market Drivers The increasing incidence of seasonal influenza outbreaks is a key factor driving the RIDT market. The need for immediate diagnosis to prevent complications and limit transmission has led to widespread use of rapid testing solutions. Government initiatives aimed at strengthening healthcare infrastructure and improving disease surveillance are also supporting market growth. The rising elderly population, which is more vulnerable to influenza-related complications, further accelerates demand for quick diagnostic tools. Moreover, growing awareness among healthcare providers and patients regarding early detection and treatment is boosting the utilization of RIDTs. Their cost-effectiveness and convenience compared to conventional laboratory testing methods also contribute to their growing popularity. Business Opportunity The RIDT market offers substantial opportunities for innovation and expansion. The increasing preference for home-based testing and portable diagnostic devices is creating new growth avenues for manufacturers. Companies are investing in research and development to introduce advanced products with improved accuracy, faster turnaround times, and user-friendly features. Emerging economies, particularly in Asia Pacific and Latin America, present significant opportunities due to expanding healthcare infrastructure and rising healthcare spending. Strategic partnerships and technological advancements, especially in molecular diagnostics, are expected to drive product innovation and enhance market competitiveness. Region Analysis North America dominates the RIDT market due to its well-established healthcare infrastructure, high awareness levels, and strong presence of leading diagnostic companies. Favorable reimbursement policies and government support further strengthen the market in this region. Europe also holds a considerable share, supported by increased healthcare investments and a strong focus on infectious disease control. The Asia Pacific region is expected to experience the fastest growth, driven by a large population base, rising influenza cases, and improving access to healthcare services. Countries such as China and India are making significant investments in diagnostic technologies, contributing to regional market expansion. Meanwhile, Latin America and the Middle East & Africa are gradually emerging as promising markets due to improving healthcare facilities and growing awareness of rapid diagnostic testing. Key Players The RIDT market is characterized by the presence of several prominent players focusing on product innovation and strategic expansion. Key companies operating in the market include: • Abbott Laboratories • F. Hoffmann-La Roche Ltd. (Roche Diagnostics) • Thermo Fisher Scientific Inc. • QuidelOrtho Corporation (Quidel Corporation) • Becton, Dickinson and Company (BD) • DiaSorin S.p.A. • Meridian Bioscience, Inc. • Sekisui Diagnostics • Hologic, Inc. • Bio-Rad Laboratories, Inc. • Siemens Healthineers AG • Luminex Corporation (now part of DiaSorin) • Analytik Jena AG (Endress+Hauser Group) • Princeton BioMeditech Corporation • Coris BioConcept These companies are continuously working to enhance their product portfolios and expand their global presence through innovation and strategic collaborations. Segmentation The Rapid Influenza Diagnostic Testing (RIDT) market is segmented based on product type, test type, technology, end user, and region. By Product Type • Conventional RIDTs • Digital RIDTs By Test Type • Influenza A Tests • Influenza B Tests • Influenza A+B Combination Tests By Technology • Immunochromatographic Assays • Lateral Flow Assays • Molecular Diagnostics (PCR & NAAT) • Immunofluorescence Assays By End User • Hospitals • Diagnostic Laboratories • Clinics • Research Institutes By Region • North America • Europe • Asia Pacific • Latin America • Middle East & Africa Table of Contents1. Executive Summary1.1. Global Rapid Influenza Diagnostic Testing Ridt Market Snapshot 1.2. Future Projections 1.3. Key Market Trends 1.4. Regional Snapshot, by Value, 2026 1.5. Analyst Recommendations 2. Market Overview 2.1. Market Definitions and Segmentations 2.2. Market Dynamics 2.2.1. Drivers 2.2.2. Restraints 2.2.3. Market Opportunities 2.3. Value Chain Analysis 2.4. COVID-19 Impact Analysis 2.5. Porter's Five Forces Analysis 2.6. Impact of Russia-Ukraine Conflict 2.7. PESTLE Analysis 2.8. Regulatory Analysis 2.9. Price Trend Analysis 2.9.1. Current Prices and Future Projections, 2025-2033 2.9.2. Price Impact Factors 3. Global Rapid Influenza Diagnostic Testing Ridt Market Outlook, 2020 - 2033 3.1. Global Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, Value (US$ Bn), 2020-2033 3.1.1. Conventional RIDTs 3.1.2. Digital RIDTs 3.2. Global Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, Value (US$ Bn), 2020-2033 3.2.1. Influenza A Tests 3.2.2. Influenza B Tests 3.2.3. Influenza A+B Combination Tests 3.3. Global Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, Value (US$ Bn), 2020-2033 3.3.1. Immunochromatographic Assays 3.3.2. Lateral Flow Assays 3.3.3. Molecular Diagnostics (PCR & NAAT) 3.3.4. Immunofluorescence Assays 3.4. Global Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, Value (US$ Bn), 2020-2033 3.4.1. Hospitals 3.4.2. Diagnostic Laboratories 3.4.3. Clinics 3.4.4. Research Institutes 3.5. Global Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Region, Value (US$ Bn), 2020-2033 3.5.1. North America 3.5.2. Europe 3.5.3. Asia Pacific 3.5.4. Latin America 3.5.5. Middle East & Africa 4. North America Rapid Influenza Diagnostic Testing Ridt Market Outlook, 2020 - 2033 4.1. North America Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, Value (US$ Bn), 2020-2033 4.1.1. Conventional RIDTs 4.1.2. Digital RIDTs 4.2. North America Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, Value (US$ Bn), 2020-2033 4.2.1. Influenza A Tests 4.2.2. Influenza B Tests 4.2.3. Influenza A+B Combination Tests 4.3. North America Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, Value (US$ Bn), 2020-2033 4.3.1. Immunochromatographic Assays 4.3.2. Lateral Flow Assays 4.3.3. Molecular Diagnostics (PCR & NAAT) 4.3.4. Immunofluorescence Assays 4.4. North America Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, Value (US$ Bn), 2020-2033 4.4.1. Hospitals 4.4.2. Diagnostic Laboratories 4.4.3. Clinics 4.4.4. Research Institutes 4.5. North America Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Country, Value (US$ Bn), 2020-2033 4.5.1. U.S. Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 4.5.2. U.S. Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 4.5.3. U.S. Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 4.5.4. U.S. Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 4.5.5. Canada Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 4.5.6. Canada Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 4.5.7. Canada Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 4.5.8. Canada Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 4.6. BPS Analysis/Market Attractiveness Analysis 5. Europe Rapid Influenza Diagnostic Testing Ridt Market Outlook, 2020 - 2033 5.1. Europe Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, Value (US$ Bn), 2020-2033 5.1.1. Conventional RIDTs 5.1.2. Digital RIDTs 5.2. Europe Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, Value (US$ Bn), 2020-2033 5.2.1. Influenza A Tests 5.2.2. Influenza B Tests 5.2.3. Influenza A+B Combination Tests 5.3. Europe Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, Value (US$ Bn), 2020-2033 5.3.1. Immunochromatographic Assays 5.3.2. Lateral Flow Assays 5.3.3. Molecular Diagnostics (PCR & NAAT) 5.3.4. Immunofluorescence Assays 5.4. Europe Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, Value (US$ Bn), 2020-2033 5.4.1. Hospitals 5.4.2. Diagnostic Laboratories 5.4.3. Clinics 5.4.4. Research Institutes 5.5. Europe Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Country, Value (US$ Bn), 2020-2033 5.5.1. Germany Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 5.5.2. Germany Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 5.5.3. Germany Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 5.5.4. Germany Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 5.5.5. Italy Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 5.5.6. Italy Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 5.5.7. Italy Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 5.5.8. Italy Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 5.5.9. France Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 5.5.10. France Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 5.5.11. France Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 5.5.12. France Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 5.5.13. U.K. Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 5.5.14. U.K. Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 5.5.15. U.K. Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 5.5.16. U.K. Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 5.5.17. Spain Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 5.5.18. Spain Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 5.5.19. Spain Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 5.5.20. Spain Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 5.5.21. Russia Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 5.5.22. Russia Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 5.5.23. Russia Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 5.5.24. Russia Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 5.5.25. Rest of Europe Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 5.5.26. Rest of Europe Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 5.5.27. Rest of Europe Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 5.5.28. Rest of Europe Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 5.6. BPS Analysis/Market Attractiveness Analysis 6. Asia Pacific Rapid Influenza Diagnostic Testing Ridt Market Outlook, 2020 - 2033 6.1. Asia Pacific Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, Value (US$ Bn), 2020-2033 6.1.1. Conventional RIDTs 6.1.2. Digital RIDTs 6.2. Asia Pacific Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, Value (US$ Bn), 2020-2033 6.2.1. Influenza A Tests 6.2.2. Influenza B Tests 6.2.3. Influenza A+B Combination Tests 6.3. Asia Pacific Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, Value (US$ Bn), 2020-2033 6.3.1. Immunochromatographic Assays 6.3.2. Lateral Flow Assays 6.3.3. Molecular Diagnostics (PCR & NAAT) 6.3.4. Immunofluorescence Assays 6.4. Asia Pacific Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, Value (US$ Bn), 2020-2033 6.4.1. Hospitals 6.4.2. Diagnostic Laboratories 6.4.3. Clinics 6.4.4. Research Institutes 6.5. Asia Pacific Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Country, Value (US$ Bn), 2020-2033 6.5.1. China Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 6.5.2. China Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 6.5.3. China Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 6.5.4. China Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 6.5.5. Japan Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 6.5.6. Japan Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 6.5.7. Japan Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 6.5.8. Japan Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 6.5.9. South Korea Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 6.5.10. South Korea Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 6.5.11. South Korea Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 6.5.12. South Korea Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 6.5.13. India Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 6.5.14. India Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 6.5.15. India Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 6.5.16. India Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 6.5.17. Southeast Asia Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 6.5.18. Southeast Asia Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 6.5.19. Southeast Asia Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 6.5.20. Southeast Asia Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 6.5.21. Rest of SAO Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 6.5.22. Rest of SAO Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 6.5.23. Rest of SAO Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 6.5.24. Rest of SAO Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 6.6. BPS Analysis/Market Attractiveness Analysis 7. Latin America Rapid Influenza Diagnostic Testing Ridt Market Outlook, 2020 - 2033 7.1. Latin America Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, Value (US$ Bn), 2020-2033 7.1.1. Conventional RIDTs 7.1.2. Digital RIDTs 7.2. Latin America Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, Value (US$ Bn), 2020-2033 7.2.1. Influenza A Tests 7.2.2. Influenza B Tests 7.2.3. Influenza A+B Combination Tests 7.3. Latin America Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, Value (US$ Bn), 2020-2033 7.3.1. Immunochromatographic Assays 7.3.2. Lateral Flow Assays 7.3.3. Molecular Diagnostics (PCR & NAAT) 7.3.4. Immunofluorescence Assays 7.4. Latin America Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, Value (US$ Bn), 2020-2033 7.4.1. Hospitals 7.4.2. Diagnostic Laboratories 7.4.3. Clinics 7.4.4. Research Institutes 7.5. Latin America Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Country, Value (US$ Bn), 2020-2033 7.5.1. Brazil Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 7.5.2. Brazil Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 7.5.3. Brazil Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 7.5.4. Brazil Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 7.5.5. Mexico Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 7.5.6. Mexico Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 7.5.7. Mexico Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 7.5.8. Mexico Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 7.5.9. Argentina Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 7.5.10. Argentina Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 7.5.11. Argentina Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 7.5.12. Argentina Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 7.5.13. Rest of LATAM Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 7.5.14. Rest of LATAM Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 7.5.15. Rest of LATAM Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 7.5.16. Rest of LATAM Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 7.6. BPS Analysis/Market Attractiveness Analysis 8. Middle East & Africa Rapid Influenza Diagnostic Testing Ridt Market Outlook, 2020 - 2033 8.1. Middle East & Africa Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, Value (US$ Bn), 2020-2033 8.1.1. Conventional RIDTs 8.1.2. Digital RIDTs 8.2. Middle East & Africa Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, Value (US$ Bn), 2020-2033 8.2.1. Influenza A Tests 8.2.2. Influenza B Tests 8.2.3. Influenza A+B Combination Tests 8.3. Middle East & Africa Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, Value (US$ Bn), 2020-2033 8.3.1. Immunochromatographic Assays 8.3.2. Lateral Flow Assays 8.3.3. Molecular Diagnostics (PCR & NAAT) 8.3.4. Immunofluorescence Assays 8.4. Middle East & Africa Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, Value (US$ Bn), 2020-2033 8.4.1. Hospitals 8.4.2. Diagnostic Laboratories 8.4.3. Clinics 8.4.4. Research Institutes 8.5. Middle East & Africa Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Country, Value (US$ Bn), 2020-2033 8.5.1. GCC Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 8.5.2. GCC Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 8.5.3. GCC Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 8.5.4. GCC Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 8.5.5. South Africa Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 8.5.6. South Africa Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 8.5.7. South Africa Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 8.5.8. South Africa Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 8.5.9. Egypt Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 8.5.10. Egypt Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 8.5.11. Egypt Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 8.5.12. Egypt Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 8.5.13. Nigeria Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 8.5.14. Nigeria Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 8.5.15. Nigeria Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 8.5.16. Nigeria Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 8.5.17. Rest of Middle East Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Product Type, 2020-2033 8.5.18. Rest of Middle East Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Test Type, 2020-2033 8.5.19. Rest of Middle East Rapid Influenza Diagnostic Testing Ridt Market Outlook, by Technology, 2020-2033 8.5.20. Rest of Middle East Rapid Influenza Diagnostic Testing Ridt Market Outlook, by End User, 2020-2033 8.6. BPS Analysis/Market Attractiveness Analysis 9. Competitive Landscape 9.1. Company Vs Segment Heatmap 9.2. Company Market Share Analysis, 2025 9.3. Competitive Dashboard 9.4. Company Profiles 9.4.1. Abbott Laboratories 9.4.1.1. Company Overview 9.4.1.2. Product Portfolio 9.4.1.3. Financial Overview 9.4.1.4. Business Strategies and Developments 9.4.2. F. Hoffmann-La Roche Ltd. (Roche Diagnostics) 9.4.3. Thermo Fisher Scientific Inc. 9.4.4. QuidelOrtho Corporation (Quidel Corporation) 9.4.5. Becton, Dickinson and Company (BD) 9.4.6. DiaSorin S.p.A. 9.4.7. Meridian Bioscience, Inc. 9.4.8. Sekisui Diagnostics 9.4.9. Hologic, Inc. 9.4.10. Bio-Rad Laboratories, Inc. 9.4.11. Siemens Healthineers AG 9.4.12. Luminex Corporation (now part of DiaSorin) 9.4.13. Analytik Jena AG (Endress+Hauser Group) 9.4.14. Princeton BioMeditech Corporation 9.4.15. Coris BioConcept 10. Appendix 10.1. Research Methodology 10.2. Report Assumptions 10.3. Acronyms and Abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（食品）の最新刊レポート
Fairfield Market Research社の 食料・飲料分野 での最新刊レポート
本レポートと同じKEY WORD（diagnostic）の最新刊レポートよくあるご質問Fairfield Market Research社はどのような調査会社ですか?Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
